# DoD Psychedelic Treatment Research Clinical Trial Award

Source: https://welltoldgrants.com/grants/ht942524dmrdpptrcta-dod-psychedelic-treatment-research-clinical-trial-award/  
Official notice: https://www.grants.gov/search-results-detail/355725

> Defense Health Agency Contracting Activity - DHACA offered grants to colleges and universities and state and local governments. It expected to make about 2 awards worth $9.8 million in total. Applications closed on October 4, 2024.

| Field | Value |
|---|---|
| Opportunity number | HT942524DMRDPPTRCTA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | October 4, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 2 |
| Total funding | $9.8 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- State governments
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

-A department or agency of the federal government or a state government -An academic institution -A research foundation partnering with a federal government organization -Federal government organizations

## What the grant funds

The intent of the DMRDP PTRCTA is to support clinical trials with eligible U.S. Service Members to evaluate treatments for post-traumatic stress disorder (PTSD) and/or traumatic brain injury (TBI) involving the use of covered psychedelic substances. Applicants must select at least one of the two covered conditions (PTSD, TBI, or both) and one or more of the covered psychedelic substances listed below. Treatment may involve the use of covered psychedelic substances alone or in conjunction with other evidence-based treatments. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. Covered psychedelic substances include: • 3,4-Methylenedioxy-methamphetamine (commonly known as “MDMA”) • psilocybin • ibogaine • 5-Methoxy-N,N-dimethyltryptamine (commonly known as “5-MeO-DMT”) • plant-based alternative therapies Per Section 723 of the National Defense Authorization Act for Fiscal Year 2024, the “Secretary of Defense may authorize any member of the Armed Forces serving on active duty who is diagnosed with a covered condition (PTSD or TBI) to participate in a clinical trial that is conducted using funding awarded under this section and is authorized pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355), without regard to— (1) whether the clinical trial involves a substance included in the schedule under section 202 of the Controlled Substances Act (21 U.S.C. 812); or (2) section 912a of title 10, United States Code (article 112a of the Uniform Code of Military Justice).” Military Relevance and Military Service Collaboration: Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families.

## Questions people ask

### Is HT942524DMRDPPTRCTA still open?

No. It closed on October 4, 2024. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Psychedelic Treatment Research Clinical Trial Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from colleges and universities and state and local governments. The notice adds further conditions, so read its eligibility section.

### What is the deadline for DoD Psychedelic Treatment Research Clinical Trial Award?

Closed October 4, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $9.8 million in total across about 2 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.